Company intelligence / Profile preview

Hydratis

Ownership: Private
Development stage: Commercial

Overview

Hydratis offers a range of effervescent tablets containing electrolytes and trace elements designed to optimize water absorption for improved hydration. The products are available in thousands of pharmacies across France, Belgium, Malta, Luxembourg, French overseas territories, as well as retail outlets like Monoprix. They are suitable for both daily use and specific situations such as sports or travel. The company emphasizes a low-sugar formula with natural flavors.

Therapeutic areas: GastroenterologyMetabolic DisordersOther
Modalities: Non-pharmacological therapyElectrolyte supplementOral rehydration solution (ORS) inspired product
Industry: Food & Nutrition

Partnerships

Distribution through pharmacy networks in France/Belgium/Malta/Luxembourg/French overseas territoriesRetail partnership with Monoprix Health Corner

Beyond the preview

Go deeper on Hydratis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hydratis.

Explore the full profile